Management of Atrial Fibrillation with Rapid Ventricular Response

Assessment and Initial Management

When diltiazem infusion is at maximum dose and inadequate rate control persists in atrial fibrillation with rapid ventricular response, the American College of Cardiology and European Heart Society recommend adding intravenous amiodarone as the next step in management 1, 2
Verify that the maximum diltiazem dose has been reached and that the patient still has inadequate rate control, according to the American Heart Association 3
Assess left ventricular function, as this will guide subsequent medication choices, as recommended by the European Society of Cardiology 4
Evaluate for signs of hemodynamic instability that might warrant immediate electrical cardioversion rather than additional medications, according to the American College of Cardiology 2

For patients with preserved LVEF (>40%), the European Heart Society recommends adding intravenous amiodarone (150 mg over 10 minutes, followed by 1 mg/min infusion for 6 hours, then 0.5 mg/min) 5, 2
Consider adding digoxin as an adjunctive therapy for patients with preserved LVEF (>40%), with dosing of 0.25-0.5 mg IV over several minutes, as recommended by the American College of Cardiology 5, 3
For patients with reduced LVEF (≤40%), the American College of Cardiology recommends adding intravenous amiodarone (same dosing as above) 1, 2
Add digoxin (same dosing as above) for patients with reduced LVEF (≤40%), as recommended by the European Heart Society 2, 3
Avoid additional calcium channel blockers due to negative inotropic effects, according to the European Heart Society 5, 4

The European Heart Society recommends dosing of amiodarone: After initial bolus, follow with 900 mg IV over 24 hours diluted in 500-1000 mL via a central venous cannula 5
When using multiple rate-controlling agents, carefully monitor for bradycardia and hypotension, as recommended by the American Heart Association 3
For patients with accessory pathways, the American College of Cardiology recommends avoiding diltiazem, beta-blockers, and digoxin; consider procainamide or ibutilide instead 2, 6

Monitor heart rate, blood pressure, and oxygen saturation continuously during medication adjustments, as recommended by the European Society of Cardiology 4
Target heart rate should be <110 bpm at rest (lenient control) unless symptoms persist, which may warrant stricter control, according to the American College of Cardiology 3
Reassess the need for rhythm control strategy if rate control remains difficult to achieve, as recommended by the European Heart Society 1